Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TERN, XBI, CYTK, QQQ, KOD, and represent 35.26% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: QQQ (+$58M), TERN (+$56M), CYTK (+$51M), IWM (+$50M), BMY (+$30M), ALMS (+$28M), KOD (+$25M), CLDX (+$18M), ANIP (+$17M), BBIO (+$16M).
- Started 24 new stock positions in NVO, ANL, PMN, Centessa Pharmaceuticals, ARWR, CRDL, DFTX, ACAD, EYPT, OCGN. BMY, REPL, AVR, BBIO, KYMR, TECX, ORKA, IWM, PVLA, ELVN, VERA, QQQ, PASG, CLDX.
- Reduced shares in these 10 stocks: CDTX (-$127M), AMGN (-$80M), RAPT (-$32M), , JAZZ (-$28M), OMER (-$26M), CORT (-$20M), CRNX (-$17M), , CTMX (-$14M).
- Sold out of its positions in ADMA, AGIO, AMGN, ANEB, Apellis Pharmaceuticals, AQST, CPRX, CELC, CGON, CDTX.
- Ikarian Capital was a net seller of stock by $-32M.
- Ikarian Capital has $1.2B in assets under management (AUM), dropping by -3.98%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 139 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Terns Pharmaceuticals (TERN) | 11.4 | $140M | +66% | 2.7M | 52.72 |
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 8.3 | $102M | -5% | 800k | 127.73 |
|
| Cytokinetics Com New (CYTK) | 6.7 | $82M | +168% | 1.2M | 65.91 |
|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 4.7 | $58M | NEW | 100k | 577.18 |
|
| Kodiak Sciences (KOD) | 4.2 | $52M | +89% | 1.4M | 38.12 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 4.0 | $50M | NEW | 200k | 248.00 |
|
| Abivax Sa Sponsored Ads (ABVX) | 3.1 | $38M | +5% | 351k | 108.14 |
|
| Alumis (ALMS) | 2.6 | $33M | +600% | 1.5M | 22.03 |
|
| Bristol Myers Squibb Put Option (BMY) | 2.5 | $30M | NEW | 500k | 60.65 |
|
| Capricor Therapeutics Com New (CAPR) | 2.2 | $27M | +51% | 878k | 30.40 |
|
| Revolution Medicines (RVMD) | 2.0 | $25M | +10% | 258k | 97.25 |
|
| Vaxcyte (PCVX) | 2.0 | $25M | +13% | 429k | 58.11 |
|
| Praxis Precision Medicines I Com New (PRAX) | 1.9 | $23M | -17% | 72k | 322.19 |
|
| Biosante Pharmaceuticals (ANIP) | 1.9 | $23M | +258% | 297k | 76.90 |
|
| Harrow Health (HROW) | 1.6 | $19M | -21% | 543k | 35.26 |
|
| Relmada Therapeutics (RLMD) | 1.5 | $19M | -12% | 2.7M | 6.96 |
|
| Celldex Therapeutics Com New (CLDX) | 1.5 | $18M | NEW | 575k | 31.72 |
|
| Tenax Therapeutics Com New (TENX) | 1.5 | $18M | +16% | 1.1M | 15.99 |
|
| Ionis Pharmaceuticals (IONS) | 1.5 | $18M | -19% | 239k | 75.09 |
|
| Olema Pharmaceuticals (OLMA) | 1.4 | $17M | +19% | 1.1M | 14.91 |
|
| Bridgebio Pharma (BBIO) | 1.3 | $16M | NEW | 219k | 74.26 |
|
| Novo-nordisk A S Adr Call Option (NVO) | 1.2 | $15M | NEW | 400k | 36.75 |
|
| Karyopharm Therapeutics Com New (KPTI) | 1.2 | $14M | +372% | 2.6M | 5.57 |
|
| Pharvaris N V (PHVS) | 1.1 | $14M | 487k | 28.25 |
|
|
| Connect Biopharma Hldgs SHS (CNTB) | 1.1 | $14M | +12% | 5.5M | 2.43 |
|
| Bright Minds Biosciences Com New (DRUG) | 1.0 | $12M | +4% | 167k | 72.97 |
|
| Oruka Therapeutics (ORKA) | 1.0 | $12M | NEW | 242k | 49.05 |
|
| Maze Therapeatics (MAZE) | 1.0 | $12M | -38% | 393k | 29.85 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.9 | $12M | 515k | 22.48 |
|
|
| Soleno Therapeutics | 0.9 | $12M | -42% | 344k | 33.48 |
|
| Vera Therapeutics Cl A (VERA) | 0.9 | $11M | NEW | 272k | 40.23 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $11M | +185% | 808k | 13.06 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $10M | -6% | 483k | 20.95 |
|
| Eyepoint Com New Call Option (EYPT) | 0.8 | $9.5M | NEW | 741k | 12.89 |
|
| Eupraxia Pharmaceuticals (EPRX) | 0.7 | $8.8M | +99% | 1.2M | 7.24 |
|
| Damora Therapeutics Com New (DMRA) | 0.7 | $8.7M | +17% | 336k | 25.90 |
|
| Avalo Therapeutics Com New Call Option (AVTX) | 0.7 | $8.4M | +527% | 560k | 14.93 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 0.7 | $8.1M | NEW | 65k | 124.65 |
|
| Fulcrum Therapeutics (FULC) | 0.7 | $8.0M | -23% | 1.0M | 7.67 |
|
| Spruce Biosciences Com New (SPRB) | 0.6 | $7.9M | 121k | 65.35 |
|
|
| Inventiva Sa Ads (IVA) | 0.6 | $7.8M | +184% | 1.4M | 5.49 |
|
| Jade Biosciences Com New (JBIO) | 0.6 | $7.2M | +70% | 512k | 14.05 |
|
| Ocugen (OCGN) | 0.6 | $7.2M | NEW | 4.0M | 1.81 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $7.1M | +48% | 1.2M | 5.95 |
|
| Ovid Therapeutics (OVID) | 0.5 | $6.4M | +1069% | 2.9M | 2.22 |
|
| Eli Lilly & Co. (LLY) | 0.5 | $6.0M | -52% | 6.5k | 919.77 |
|
| Uniqure Nv Call Call Option | 0.5 | $5.8M | +236% | 355k | 16.35 |
|
| Alpha Cognition Com New (ACOG) | 0.5 | $5.8M | 1.1M | 5.49 |
|
|
| Pelthos Therapeutics Com Shs (PTHS) | 0.4 | $5.4M | 257k | 21.01 |
|
|
| Surrozen Com New (SRZN) | 0.4 | $5.0M | +163% | 173k | 29.13 |
|
| Tectonic Therapeutic (TECX) | 0.4 | $4.9M | NEW | 158k | 30.91 |
|
| Alector (ALEC) | 0.4 | $4.5M | 2.1M | 2.15 |
|
|
| Kymera Therapeutics Put Option (KYMR) | 0.3 | $4.2M | NEW | 50k | 83.29 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $4.1M | 227k | 18.09 |
|
|
| Lipocine Com New (LPCN) | 0.3 | $4.1M | +154% | 509k | 7.99 |
|
| Delcath Sys Com New (DCTH) | 0.3 | $4.0M | 431k | 9.28 |
|
|
| Arvinas Ord (ARVN) | 0.3 | $3.8M | 358k | 10.60 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $3.7M | +68% | 675k | 5.53 |
|
| Cardiol Therapeutics Com Cl A (CRDL) | 0.3 | $3.7M | NEW | 2.7M | 1.35 |
|
| Arrowhead Pharmaceuticals Put Option (ARWR) | 0.3 | $3.6M | NEW | 58k | 62.70 |
|
| Biohaven (BHVN) | 0.3 | $3.5M | +94% | 413k | 8.46 |
|
| Adagio Therapeutics (IVVD) | 0.3 | $3.5M | 2.7M | 1.30 |
|
|
| Enliven Therapeutics Put Option (ELVN) | 0.3 | $3.3M | NEW | 84k | 39.20 |
|
| Annexon (ANNX) | 0.3 | $3.2M | +152% | 580k | 5.54 |
|
| Forte Biosciences Com New (FBRX) | 0.3 | $3.1M | -60% | 119k | 25.90 |
|
| Lexeo Therapeutics (LXEO) | 0.2 | $2.9M | 513k | 5.74 |
|
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.2 | $2.6M | 241k | 10.97 |
|
|
| Vir Biotechnology (VIR) | 0.2 | $2.6M | -49% | 293k | 8.96 |
|
| Nextcure Com New (NXTC) | 0.2 | $2.5M | 238k | 10.52 |
|
|
| Neumora Therapeutics (NMRA) | 0.2 | $2.5M | 1.3M | 1.95 |
|
|
| Acumen Pharmaceuticals (ABOS) | 0.2 | $2.5M | +314% | 1.1M | 2.36 |
|
| Cabaletta Bio (CABA) | 0.2 | $2.4M | 900k | 2.69 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $2.4M | +22% | 270k | 8.95 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.2 | $2.4M | 1.5M | 1.62 |
|
|
| Nuvalent Inc-a (NUVL) | 0.2 | $2.4M | -60% | 24k | 102.45 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.2 | $2.4M | -92% | 13k | 189.05 |
|
| Replimune Group Put Option (REPL) | 0.2 | $2.3M | NEW | 300k | 7.65 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 0.2 | $2.2M | 525k | 4.19 |
|
|
| Tarsus Pharmaceuticals (TARS) | 0.2 | $2.2M | 31k | 70.15 |
|
|
| Kalaris Therapeutics (KLRS) | 0.2 | $2.1M | 360k | 5.77 |
|
|
| Anteris Technologies Global (AVR) | 0.2 | $2.0M | NEW | 367k | 5.55 |
|
| Solid Biosciences Com New (SLDB) | 0.2 | $1.9M | -54% | 264k | 7.20 |
|
| Ibio Com New (IBIO) | 0.1 | $1.8M | 957k | 1.90 |
|
|
| Cumberland Pharmaceuticals (CPIX) | 0.1 | $1.8M | 553k | 3.25 |
|
|
| Silence Therapeutics Ads (SLN) | 0.1 | $1.7M | 866k | 2.00 |
|
|
| Direxion Shares Etf Trust Daily S&p Biotec (LABD) | 0.1 | $1.7M | +159% | 106k | 16.30 |
|
| Uniqure Nv SHS (QURE) | 0.1 | $1.5M | 91k | 16.35 |
|
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.1 | $1.4M | 212k | 6.60 |
|
|
| Pepgen (PEPG) | 0.1 | $1.3M | 747k | 1.77 |
|
|
| Traws Pharma Com New (TRAW) | 0.1 | $1.2M | 678k | 1.83 |
|
|
| Journey Med Corp (DERM) | 0.1 | $1.2M | 251k | 4.69 |
|
|
| Verastem Com New (VSTM) | 0.1 | $1.1M | 214k | 5.30 |
|
|
| Definium Therapeutics Com Shs (DFTX) | 0.1 | $1.1M | NEW | 59k | 18.90 |
|
| Neuronetics (STIM) | 0.1 | $1.0M | 701k | 1.45 |
|
|
| Lyell Immunopharma Com New (LYEL) | 0.1 | $824k | 41k | 20.06 |
|
|
| Kezar Life Sciences Com New | 0.1 | $758k | 102k | 7.42 |
|
|
| Immunic | 0.1 | $749k | 675k | 1.11 |
|
|
| Centessa Pharmaceuticals Sponsored Ads | 0.1 | $719k | NEW | 18k | 39.72 |
|
| Kalvista Pharmaceuticals | 0.1 | $707k | 35k | 20.13 |
|
|
| Promis Neurosciences Com Shs (PMN) | 0.1 | $699k | NEW | 55k | 12.70 |
|
| Insmed Com Par $.01 (INSM) | 0.1 | $689k | -76% | 4.2k | 163.52 |
|
| Cybin Com New (HELP) | 0.1 | $634k | 132k | 4.80 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $626k | NEW | 28k | 22.26 |
|
| Wave Life Sciences SHS (WVE) | 0.1 | $618k | 85k | 7.25 |
|
|
| Equillium (EQ) | 0.0 | $607k | 304k | 2.00 |
|
|
| Passage Bio Com New (PASG) | 0.0 | $535k | NEW | 68k | 7.85 |
|
| Fractyl Health (GUTS) | 0.0 | $504k | 1.1M | 0.46 |
|
|
| Palisade Bio (PALI) | 0.0 | $481k | 275k | 1.75 |
|
|
| Immatics SHS (IMTX) | 0.0 | $478k | 49k | 9.84 |
|
|
| Viking Therapeutics (VKTX) | 0.0 | $316k | 9.7k | 32.54 |
|
|
| Sangamo Biosciences | 0.0 | $301k | 1.2M | 0.25 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $297k | 519k | 0.57 |
|
|
| Veru Com New (VERU) | 0.0 | $295k | 134k | 2.21 |
|
|
| Evaxion As Sponsored Ads (EVAX) | 0.0 | $278k | 75k | 3.72 |
|
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.0 | $257k | 165k | 1.56 |
|
|
| Adlai Nortye Sponsored Ads (ANL) | 0.0 | $235k | NEW | 34k | 6.92 |
|
| Macrogenics (MGNX) | 0.0 | $216k | 75k | 2.89 |
|
|
| Voyager Therapeutics (VYGR) | 0.0 | $205k | 53k | 3.86 |
|
|
| Sensei Biotherapeutics Com New (FTH) | 0.0 | $200k | -70% | 6.4k | 31.52 |
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $193k | 47k | 4.07 |
|
|
| Vyne Therapeutics (VYNE) | 0.0 | $158k | 265k | 0.60 |
|
|
| Hyperliquid Strategies (PURR) | 0.0 | $153k | 30k | 5.09 |
|
|
| Nyxoah S A SHS (NYXH) | 0.0 | $138k | 47k | 2.92 |
|
|
| Cartesian Therapeutics Com New (RNAC) | 0.0 | $128k | 21k | 6.15 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $111k | 89k | 1.24 |
|
|
| CNS Pharmaceuticals (CNSP) | 0.0 | $110k | 46k | 2.40 |
|
|
| Compass Therapeutics (CMPX) | 0.0 | $95k | -97% | 18k | 5.29 |
|
| Io Biotech (IOBTQ) | 0.0 | $81k | 1.4M | 0.06 |
|
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $81k | 52k | 1.57 |
|
|
| Biomx Com New (PHGE) | 0.0 | $73k | 20k | 3.75 |
|
|
| Rezolute Com New (RZLT) | 0.0 | $50k | 17k | 3.05 |
|
|
| Mangoceuticals Com New (MGRX) | 0.0 | $50k | 138k | 0.36 |
|
|
| Shuttle Pharmactcls Hldgs In (SHPH) | 0.0 | $47k | 69k | 0.68 |
|
|
| Airsculpt Technologies (AIRS) | 0.0 | $46k | 16k | 2.83 |
|
|
| Aethlon Med Com New (AEMD) | 0.0 | $32k | 14k | 2.19 |
|
|
| Glucotrack Com New (GCTK) | 0.0 | $30k | 46k | 0.65 |
|
|
| Theriva Biologics Com New (TOVX) | 0.0 | $22k | 112k | 0.20 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $21k | 24k | 0.88 |
|
|
| Autonomix Med Com New (AMIX) | 0.0 | $7.3k | 19k | 0.39 |
|
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2026 Q1 filed May 15, 2026
- Ikarian Capital 2025 Q4 filed Feb. 18, 2026
- Ikarian Capital 2025 Q3 filed Nov. 14, 2025
- Ikarian Capital 2025 Q2 filed Aug. 14, 2025
- Ikarian Capital 2025 Q1 filed May 15, 2025
- Ikarian Capital 2024 Q4 filed Feb. 14, 2025
- Ikarian Capital 2024 Q3 filed Nov. 14, 2024
- Ikarian Capital 2024 Q2 filed Aug. 14, 2024
- Ikarian Capital 2024 Q1 restated filed May 17, 2024
- Ikarian Capital 2024 Q1 filed May 15, 2024
- Ikarian Capital 2023 Q4 filed Feb. 14, 2024
- Ikarian Capital 2023 Q3 filed Nov. 14, 2023
- Ikarian Capital 2023 Q2 filed Aug. 14, 2023
- Ikarian Capital 2023 Q1 filed May 15, 2023
- Ikarian Capital 2022 Q4 filed Feb. 14, 2023
- Ikarian Capital 2022 Q3 filed Nov. 14, 2022